Jan 27, 2022

Australian homegrown COVID-19 pipeline shows signs of maturity

Australian homegrown COVID-19 pipeline shows signs of maturity

"Starpharma Pty Ltd. has developed Viraleze, an intranasal spray for COVID-19 that is based on the company’s antiviral dendrimer, SPL-7013, which inactivates viruses by blocking the interaction between viral surface proteins and the human cell receptor proteins." Read more on BioWorld. (Free Subscription required)

 This contains certain forward-looking statements.